DeepLab, an innovative SME, has recently established itself in life sciences, applying its extensive research & advanced AI capabilities to areas like drug discovery and precision medicine. Our key products include drug screening, lead optimization, target identification through interpretable models, cancer subtype classification, generative AI for synthetic bio data and wellness capable brain computer interfaces. We seek partners who aim to employ ML for drug discovery and (pre-)clinical cases.